CHAPEL HILL – SonoVascular, a Chapel Hill-based company launched in 2018, has raised $750,000 in debt from one investor, according to an SEC filing.
CEO Daniel Estay signed the filing. Etsay’s LinkedIn profile also indicates he is a founder of the company. The company could raise up to $2 million, according to the filing.
The company has licensed technology developed at North Carolina State University, an ultrasound “drill,” according to the university.
“SonoVascular and NC State are hoping to work with industry partners to advance the technology,” WRAL TechWire reported last year.
NCSU, UNC researchers use nanotech to tackle tough blood clots
The company received a grant from the National Institutes of Health, Department of Health and Human Services, valued at $150,000, in 2020.
The company could not be reached for comment. The company is hiring a research and development engineer and eligible MAE student, according to a posting on the North Carolina State University website.
